Effect of diphenylhydantoin and related compounds on glaucoma

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31415

Patent

active

041104617

ABSTRACT:
A therapeutic method of alleviating the symptoms and relieving intraocular pressure associated with open or wide-angle glaucoma which comprises administering a compound selected from diphenylhydantoin (DPH), mephenytoin, and ethotoin in an amount ranging from 200-900 mg per day preferably on a split or divided dosage basis for a period of 2-5 months. A preferred regimen for DPH is 100 mg three times per day.

REFERENCES:
physicians Desk Reference, PDR, (1971) 25th Edition, p. 1003.
Cutting, Handbook of Pharmacology, 1969, pp. 669-671.
Becker et al., J. Clin. Endocrinol. Metab., vol. 32, No. 5, pp. 669-670 (1971).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Effect of diphenylhydantoin and related compounds on glaucoma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Effect of diphenylhydantoin and related compounds on glaucoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Effect of diphenylhydantoin and related compounds on glaucoma will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1633586

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.